---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-000163"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:32:27.604468+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Jay Panis resigns from Virpax board and committees, effective Feb 3, 2025

## Summary
- Jay Panis resigned from the Board and all committees (Audit, Compensation, Nominating/Governance).
- Resignation due to compliance requirements with his current employer, not due to any disagreement with company.
- Company will begin process to identify a qualified independent director to fill the vacancy.
- No other director departures or executive officer changes reported.

## SEC filing metadata
- accession: 0001731122-25-000163
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000163/0001731122-25-000163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000163/e6337_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-000163
- JSON: https://secwatch.observer/filing/0001731122-25-000163.json
- Plain text: https://secwatch.observer/filing/0001731122-25-000163.txt

## Key facts
- Executive change
  Jay Panis resigned as Director at Virpax Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Director
  source text: On February 3, 2025, Mr. Jaydriane (Jay) Panis, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Board of his resignation from the Board and the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000163/0001731122-25-000163-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.